Neurotech Pharmaceuticals, Inc.
Tim Scannell, CPA, currently serves as the Controller at Neurotech Pharmaceuticals, Inc. since November 2024. Prior to this role, Tim held the position of Director of Finance and Accounting at Gryphon.ai from July 2021 to December 2024. Tim's extensive experience includes serving as Senior Manager of Financial Planning and Analysis and Manager of Accounting at Collegium Pharmaceutical, Inc. from April 2018 to June 2021, as well as Senior Audit Associate and Experienced Associate at Grant Thornton LLP between February 2015 and March 2018. Earlier in their career, Tim worked as a Senior Internal Auditor at Nortek from August 2013 to January 2015 and as an Associate in Health Industries Assurance at PwC from January 2012 to July 2013. Tim holds a Master’s Degree in Accounting and a Bachelor of Business Administration in Accounting, both from the University of Rhode Island - College of Business.
This person is not in any teams
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.